Latest Close
$4.40
News
ABEO
Abeona Therapeutics Inc. News
This news view pulls recent coverage and headlines tied to ABEO.
1y Change
-$1.08 (-19.71%)
Market Cap
$251,609,680.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire • Oct 2, 2026
Read articleAbeona Therapeutics Highlights ZEVASKYN Launch Momentum, Revenue Growth at H.C. Wainwright
MarketBeat • Sep 22, 2026
Read articleAbeona Expands ZEVASKYN Network as RDEB Launch Gains Momentum
MarketBeat • Sep 22, 2026
Read articleAbeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)
GlobeNewswire • Sep 18, 2026
Read articleABEO Stock Gains On Approval For A Drug Abeona Sold, Rating For The One It Sells
Stocktwits • Sep 17, 2026
Read articleSector Update: Healthcare Stocks Edge Higher Pre-Bell Wednesday
MT Newswires • Sep 16, 2026
Read article